ConductScience.org, home

Paper54923

A molecular concept of the properdin pathway.

Medicus RG and 3 others. Proc Natl Acad Sci U S A, 1976. Cited by 94 papers, by iCite.

Cite this record

ConductScience Library. A molecular concept of the properdin pathway. Papers, record 54923. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/54923

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A molecular concept of the properdin pathway.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
94
iCite
Relative citation ratio, by iCite
2.68
iCite
Revised in PubMed
2019-05-01
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Medicus RGR G
2Schreiber RDR D
3Götze OO
4Müller-Eberhard HJH J

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement C3Major topic
Complement System ProteinsMajor topic
Models, BiologicalMajor topic
ProperdinMajor topic
Beta-Globulins
Complement C5

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14169693Properties of highly purified human properdin.J Immunol1968https://conductscience.org/library/papers/4169693PubMed
24111773C3 proactivator convertase and its mode of action.J Exp Med1972https://conductscience.org/library/papers/4111773PubMed
34207623A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement.J Exp Med1974https://conductscience.org/library/papers/4207623PubMed
44632688The alternate pathway of complement activation. The role of C3 and its inactivator (KAF).Immunology1973https://conductscience.org/library/papers/4632688PubMed
54734384Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3).J Immunol1973https://conductscience.org/library/papers/4734384PubMed
647885The membrane attack mechanism of complement. Isolation and subunit composition of the C5b-9 complex.J Exp Med1975https://conductscience.org/library/papers/47885PubMed
74808709The role of properdin in the alternate pathway of complement activation.J Exp Med1974https://conductscience.org/library/papers/4808709PubMed
85645214The demonstration in human serum of "conglutinogen-activating factor" and its effect on the third component of complement.J Immunol1968https://conductscience.org/library/papers/5645214PubMed
96019133Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.J Exp Med1967https://conductscience.org/library/papers/6019133PubMed
101056006Third component of complement (C3): structural properties in relation to functions.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/1056006PubMed
111059108Properdin: initiation of alternative complement pathway.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/1059108PubMed
121092789Immunologic injury of cultured cells infected with measles virus. I. role of IfG antibody and the alternative complement pathway.J Exp Med1975https://conductscience.org/library/papers/1092789PubMed
131159084Complete absence of the third component of complement in man.J Clin Invest1975https://conductscience.org/library/papers/1159084PubMed
141165475Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor.J Exp Med1975https://conductscience.org/library/papers/1165475PubMed
151185108Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.J Exp Med1975https://conductscience.org/library/papers/1185108PubMed
16126576Formation and composition of the C3 activating enzyme complex of the properdin system. Sequential assembly of its components on solid-phase trypsin-agarose.Z Immunitatsforsch Exp Klin Immunol1975https://conductscience.org/library/papers/126576PubMed
184105810The C3-activator system: an alternate pathway of complement activation.J Exp Med1971https://conductscience.org/library/papers/4105810PubMed
194202731Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement.J Exp Med1973https://conductscience.org/library/papers/4202731PubMed

Download CSV of references

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 94 citations.

PMIDTitleJournalYearIn PapersSource
35031611Structure and function of a family of tick-derived complement inhibitors targeting properdin.Nat Commun2022https://conductscience.org/library/papers/35031611PubMed
30141176The role of properdin in complement-mediated renal diseases: a new player in complement-inhibiting therapy?Pediatr Nephrol2019https://conductscience.org/library/papers/30141176PubMed
29167939The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?Semin Immunopathol2018https://conductscience.org/library/papers/29167939PubMed
27018802Structural basis for therapeutic inhibition of complement C5.Nat Struct Mol Biol2016https://conductscience.org/library/papers/27018802PubMed
26082779Complement System Part I - Molecular Mechanisms of Activation and Regulation.Front Immunol2015https://conductscience.org/library/papers/26082779PubMed
20382442Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complement.Immunobiology2010https://conductscience.org/library/papers/20382442PubMed
20304920Convertase inhibitory properties of Staphylococcal extracellular complement-binding protein.J Biol Chem2010https://conductscience.org/library/papers/20304920PubMed
6904360Interactions of chrysotile asbestos fibres with the complement system.Immunology1980https://conductscience.org/library/papers/6904360PubMed
6903192Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.J Exp Med1980https://conductscience.org/library/papers/6903192PubMed
6316456Synthesis of lipids or lipid-containing macromolecules in tumor cells. Relevance to host defense.Surv Immunol Res1983https://conductscience.org/library/papers/6316456PubMed
6238433The alternative pathway of complement.Springer Semin Immunopathol1984https://conductscience.org/library/papers/6238433PubMed
3307764Resolution and analysis of 'native' and 'activated' properdin.Biochem J1987https://conductscience.org/library/papers/3307764PubMed
1067618Control of the amplification convertase of complement by the plasma protein beta1H.Proc Natl Acad Sci U S A1976https://conductscience.org/library/papers/1067618PubMed
879873Changes in humoral components of host defense following burn trauma.Ann Surg1977https://conductscience.org/library/papers/879873PubMed
830792Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes.J Exp Med1977https://conductscience.org/library/papers/830792PubMed
721136Solid phase activation of alternative pathway of complement by beta-1,3-glucans and its possible role for tumour regressing activity.Immunology1978https://conductscience.org/library/papers/721136PubMed
666383Host defense against opportunist microorganisms following trauma. I. Studies to determine the association between changes in humoral components of host defense and septicemia in burned patients.Ann Surg1978https://conductscience.org/library/papers/666383PubMed
666370Host defense against opportunist microorganisms following trauma. II. Changes in complement and immunoglobulins in patients with abdominal trauma and in septic patients without trauma.Ann Surg1978https://conductscience.org/library/papers/666370PubMed
627406Binding of activated properdin to untreated erythrocytes: a new function of activated properdin.Immunology1978https://conductscience.org/library/papers/627406PubMed
590998Insoluble polyanions as activators of both pathways of complement.Immunology1977https://conductscience.org/library/papers/590998PubMed

See all 31 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
C3718PubTator's text mininghttps://conductscience.org/library/genes/718NCBI Gene
C5727PubTator's text mininghttps://conductscience.org/library/genes/727NCBI Gene
CFI3426PubTator's text mininghttps://conductscience.org/library/genes/3426NCBI Gene
CFP5199PubTator's text mininghttps://conductscience.org/library/genes/5199NCBI Gene
ERVK-3100862689PubTator's text mininghttps://conductscience.org/library/genes/100862689NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/54923

GET https://conductscience.org/api/papers/v1/54923/cited_by?page=2